Minocycline reduces plaque size in diet induced atherosclerosis via p27 Kip1

Atherosclerosis

Volumn 219, Issue 1, 2011, Pages 74-83

  Shahzad, Khurrum ^a   Thati, Madhusudhan ^a   Wang, Hongjie ^a,b   Kashif, Muhammed ^a   Wolter, Juliane ^a   Ranjan, Satish ^a   He, Tao ^a,b   Zhou, Qianxing ^a,b   Blessing, Erwin ^a   Bierhaus, Angelika ^a   Nawroth, Peter P ^a   Isermann, Berend ^a,c  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^c OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

Atherosclerosis; Minocycline; P27; PARP 1; Vascular smooth muscle cells

Indexed keywords

APOLIPOPROTEIN E; BETA ACTIN; CALPONIN; CYCLIN DEPENDENT KINASE INHIBITOR 1B; KI 67 ANTIGEN; MINOCYCLINE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; POLY(ADENOSINE DIPHOSPHATE RIBOSE);

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; ATHEROGENESIS; ATHEROSCLEROTIC PLAQUE; CELL MIGRATION; CELL PROLIFERATION; CELL STRUCTURE; CONTROLLED STUDY; DRUG MECHANISM; EX VIVO STUDY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; VASCULAR SMOOTH MUSCLE;

ANIMALS; AORTIC VALVE STENOSIS; APOLIPOPROTEINS E; ATHEROSCLEROSIS; CELL PROLIFERATION; CYCLIN-DEPENDENT KINASE INHIBITOR P27; DIET, HIGH-FAT; HUMANS; MICE; MINOCYCLINE; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; PHENANTHRENES; PLAQUE, ATHEROSCLEROTIC; POLY(ADP-RIBOSE) POLYMERASES;

EID: 80054978002     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2011.05.041     Document Type: Article

References (32)

1. Brundula V., Rewcastle N.B., Metz L.M., Bernard C.C., Yong V.W. Targeting leukocyte MMPs and transmigration: minocycline as a potential therapy for multiple sclerosis. Brain 2002, 125:1297-1308.
2. Zhu S., Stavrovskaya I.G., Drozda M., et al. Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice. Nature 2002, 417:74-78.
3. Lampl Y., Boaz M., Gilad R., et al. Minocycline treatment in acute stroke: an open-label, evaluator-blinded study. Neurology 2007, 69:1404-1410.
4. Isermann B., Vinnikov I.A., Madhusudhan T., et al. Activated protein C protects against diabetic nephropathy by inhibiting endothelial and podocyte apoptosis. Nat Med 2007, 13:1349-1358.
5. Krady J.K., Basu A., Allen C.M., et al. Minocycline reduces proinflammatory cytokine expression, microglial activation, and caspase-3 activation in a rodent model of diabetic retinopathy. Diabetes 2005, 54:1559-1565.
6. Pinney S.P., Chen H.J., Liang D., et al. Minocycline inhibits smooth muscle cell proliferation, migration and neointima formation after arterial injury. J Cardiovasc Pharmacol 2003, 42:469-476.
7. Ohshima S., Fujimoto S., Petrov A., et al. Effect of an antimicrobial agent on atherosclerotic plaques: assessment of metalloproteinase activity by molecular imaging. J Am Coll Cardiol 2010, 55:1240-1249.
8. Yao J.S., Chen Y., Zhai W., et al. Minocycline exerts multiple inhibitory effects on vascular endothelial growth factor-induced smooth muscle cell migration: the role of ERK1/2, PI3K, and matrix metalloproteinases. Circ Res 2004, 95:364-371.
9. Bicknell K.A., Surry E.L., Brooks G. Targeting the cell cycle machinery for the treatment of cardiovascular disease. J Pharm Pharmacol 2003, 55:571-591.
10. Lutgens E., de Muinck E.D., Kitslaar P.J., et al. Biphasic pattern of cell turnover characterizes the progression from fatty streaks to ruptured human atherosclerotic plaques. Cardiovasc Res 1999, 41:473-479.
11. McAllister J.P., Miller J.M. Minocycline inhibits glial proliferation in the H-Tx rat model of congenital hydrocephalus. Cerebrospinal Fluid Res 2010, 7:7.
12. Diez-Juan A., Andres V. The growth suppressor p27(Kip1) protects against diet-induced atherosclerosis. FASEB J 2001, 15:1989-1995.
13. Libby P. Inflammation in atherosclerosis. Nature 2002, 420:868-874.
14. Morgan D.O. Principles of CDK regulation. Nature 1995, 374:131-134.
15. Tanner F.C., Boehm M., Akyurek L.M., et al. Differential effects of the cyclin-dependent kinase inhibitors p27(Kip1), p21(Cip1), and p16(Ink4) on vascular smooth muscle cell proliferation. Circulation 2000, 101:2022-2025.
16. Carbone M., Rossi M.N., Cavaldesi M., et al. Poly(ADP-ribosyl)ation is implicated in the G0-G1 transition of resting cells. Oncogene 2008, 27:6083-6092.
17. Alano C.C., Kauppinen T.M., Valls A.V., Swanson R.A. Minocycline inhibits poly(ADP-ribose) polymerase-1 at nanomolar concentrations. Proc Natl Acad Sci U S A 2006, 103:9685-9690.
18. Seehaus S., Shahzad K., Kashif M., et al. Frommhold, D., Nawroth, P.P. and Isermann, B., Hypercoagulability inhibits monocyte transendothelial migration through protease-activated receptor-1-, phospholipase-Cbeta-, phosphoinositide 3-kinase-, and nitric oxide-dependent signaling in monocytes and promotes plaque stability. Circulation 2009, 120:774-784.
19. Rosenfeld M.E., Polinsky P., Virmani R., et al. Advanced atherosclerotic lesions in the innominate artery of the ApoE knockout mouse. Arterioscler Thromb Vasc Biol 2000, 20:2587-2592.
20. Yao J.S., Shen F., Young W.L., Yang G.Y. Comparison of doxycycline and minocycline in the inhibition of VEGF-induced smooth muscle cell migration. Neurochem Int 2007, 50:524-530.
21. Bendeck M.P., Conte M., Zhang M., et al. Doxycycline modulates smooth muscle cell growth, migration, and matrix remodeling after arterial injury. Am J Pathol 2002, 160:1089-1095.
22. Huang T.Y., Chu H.C., Lin Y.L., et al. Minocycline attenuates 5-fluorouracil-induced small intestinal mucositis in mouse model. Biochem Biophys Res Commun 2009, 389:634-639.
23. Tikka T., Fiebich B.L., Goldsteins G., Keinanen R., Koistinaho J. Minocycline, a tetracycline derivative, is neuroprotective against excitotoxicity by inhibiting activation and proliferation of microglia. J Neurosci 2001, 21:2580-2588.
24. Fife R.S., Rougraff B.T., Proctor C., Sledge G.W. Inhibition of proliferation and induction of apoptosis by doxycycline in cultured human osteosarcoma cells. J Lab Clin Med 1997, 130:530-534.
25. Fife R.S., Sledge G.W. Effects of doxycycline on in vitro growth, migration, and gelatinase activity of breast carcinoma cells. J Lab Clin Med 1995, 125:407-411.
26. Orr A.W., Hastings N.E., Blackman B.R., Wamhoff B.R. Complex regulation and function of the inflammatory smooth muscle cell phenotype in atherosclerosis. J Vasc Res 2010, 47:168-180.
27. Tanner F.C., Yang Z.Y., Duckers E., et al. Expression of cyclin-dependent kinase inhibitors in vascular disease. Circ Res 1998, 82:396-403.
28. Sakamaki J., Daitoku H., Yoshimochi K., Miwa M., Fukamizu A. Regulation of FOXO1-mediated transcription and cell proliferation by PARP-1. Biochem Biophys Res Commun 2009, 382:497-502.
29. Abid M.R., Yano K., Guo S., et al. Forkhead transcription factors inhibit vascular smooth muscle cell proliferation and neointimal hyperplasia. J Biol Chem 2005, 280:29864-29873.
30. Libby P., Tanaka H. The molecular bases of restenosis. Prog Cardiovasc Dis 1997, 40:97-106.
31. Oumouna-Benachour K., Hans C.P., Suzuki Y., et al. Poly(ADP-ribose) polymerase inhibition reduces atherosclerotic plaque size and promotes factors of plaque stability in apolipoprotein E-deficient mice: effects on macrophage recruitment, nuclear factor-kappaB nuclear translocation, and foam cell death. Circulation 2007, 115:2442-2450.
32. Luccarini I., Ballerini C., Biagioli T., et al. Combined treatment with atorvastatin and minocycline suppresses severity of EAE. Exp Neurol 2008, 211:214-226.